Pasithea Historical Income Statement

KTTAW Stock

USD 0.02 0 9.90%

Historical analysis of Pasithea Therapeutics income statement accounts such as Total Other Income Expense Net of 362.6 M can show how well Pasithea Therapeutics Corp performed in making a profits. Evaluating Pasithea Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Pasithea Therapeutics's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Pasithea Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Pasithea Therapeutics is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Pasithea Income Statement Analysis

Pasithea Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Pasithea Therapeutics shareholders. The income statement also shows Pasithea investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Pasithea Therapeutics Income Statement Chart

At this time, Pasithea Therapeutics' Depreciation And Amortization is fairly stable compared to the past year. Total Operating Expenses is likely to climb to about 15 B in 2025, despite the fact that Operating Income is likely to grow to (13.5 B).

Other Operating Expenses Total Operating Expenses Selling General Administrative Cost Of Revenue

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Pasithea Therapeutics. It is also known as Pasithea Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Cost Of Revenue

Cost of Revenue is found on Pasithea Therapeutics income statement and represents the costs associated with goods and services Pasithea Therapeutics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Pasithea Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Pasithea Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2022	2023	2024	2025 (projected)
Other Operating Expenses	15.3M	16.0M	18.4M	9.9M
Depreciation And Amortization	5.1K	648.5K	745.7K	783.0K

Other Operating Expenses Depreciation And Amortization

Pasithea Therapeutics income statement Correlations

	Depreciation And Amortization	Other Operating Expenses	Operating Income	Ebit	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Net Interest Income	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Net Income From Continuing Ops	Cost Of Revenue	Reconciled Depreciation	Selling And Marketing Expenses
Depreciation And Amortization		0.74	-0.84	-0.81	-0.84	0.84	-0.84	0.84	-0.84	1.0	0.98	-0.81	0.46	0.18	-0.94	-0.81	0.99	0.94	1.0
Other Operating Expenses	0.74		-0.59	-0.97	-0.59	0.58	-0.59	0.58	-0.59	0.77	0.74	-0.96	0.47	0.65	-0.55	-0.95	0.82	0.84	0.77
Operating Income	-0.84	-0.59		0.63	1.0	-1.0	1.0	-1.0	1.0	-0.83	-0.92	0.67	0.1	0.17	0.7	0.61	-0.83	-0.74	-0.83
Ebit	-0.81	-0.97	0.63		0.63	-0.63	0.63	-0.63	0.63	-0.85	-0.81	0.98	-0.52	-0.63	0.64	0.98	-0.88	-0.85	-0.85
Ebitda	-0.84	-0.59	1.0	0.63		-1.0	1.0	-1.0	1.0	-0.83	-0.92	0.67	0.1	0.17	0.7	0.61	-0.83	-0.74	-0.83
Total Operating Expenses	0.84	0.58	-1.0	-0.63	-1.0		-1.0	1.0	-1.0	0.84	0.92	-0.67	-0.1	-0.17	-0.7	-0.61	0.83	0.73	0.84
Income Before Tax	-0.84	-0.59	1.0	0.63	1.0	-1.0		-1.0	1.0	-0.83	-0.92	0.67	0.1	0.17	0.7	0.61	-0.83	-0.74	-0.83
Total Other Income Expense Net	0.84	0.58	-1.0	-0.63	-1.0	1.0	-1.0		-1.0	0.84	0.92	-0.67	-0.1	-0.17	-0.7	-0.62	0.83	0.73	0.84
Net Income	-0.84	-0.59	1.0	0.63	1.0	-1.0	1.0	-1.0		-0.83	-0.92	0.67	0.1	0.17	0.7	0.61	-0.83	-0.74	-0.83
Income Tax Expense	1.0	0.77	-0.83	-0.85	-0.83	0.84	-0.83	0.84	-0.83		0.98	-0.84	0.47	0.22	-0.93	-0.84	1.0	0.95	1.0
Net Interest Income	0.98	0.74	-0.92	-0.81	-0.92	0.92	-0.92	0.92	-0.92	0.98		-0.81	0.3	0.1	-0.89	-0.8	0.98	0.91	0.98
Interest Expense	-0.81	-0.96	0.67	0.98	0.67	-0.67	0.67	-0.67	0.67	-0.84	-0.81		-0.44	-0.62	0.59	0.99	-0.88	-0.82	-0.84
Selling General Administrative	0.46	0.47	0.1	-0.52	0.1	-0.1	0.1	-0.1	0.1	0.47	0.3	-0.44		0.68	-0.56	-0.54	0.46	0.54	0.47
Total Revenue	0.18	0.65	0.17	-0.63	0.17	-0.17	0.17	-0.17	0.17	0.22	0.1	-0.62	0.68		-0.05	-0.67	0.28	0.31	0.22
Gross Profit	-0.94	-0.55	0.7	0.64	0.7	-0.7	0.7	-0.7	0.7	-0.93	-0.89	0.59	-0.56	-0.05		0.62	-0.89	-0.89	-0.93
Net Income From Continuing Ops	-0.81	-0.95	0.61	0.98	0.61	-0.61	0.61	-0.62	0.61	-0.84	-0.8	0.99	-0.54	-0.67	0.62		-0.88	-0.83	-0.84
Cost Of Revenue	0.99	0.82	-0.83	-0.88	-0.83	0.83	-0.83	0.83	-0.83	1.0	0.98	-0.88	0.46	0.28	-0.89	-0.88		0.95	1.0
Reconciled Depreciation	0.94	0.84	-0.74	-0.85	-0.74	0.73	-0.74	0.73	-0.74	0.95	0.91	-0.82	0.54	0.31	-0.89	-0.83	0.95		0.95
Selling And Marketing Expenses	1.0	0.77	-0.83	-0.85	-0.83	0.84	-0.83	0.84	-0.83	1.0	0.98	-0.84	0.47	0.22	-0.93	-0.84	1.0	0.95

Click cells to compare fundamentals

Pasithea Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Pasithea Stock Analysis

When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Pasithea Historical Income Statement

About Pasithea Income Statement Analysis

Pasithea Therapeutics Income Statement Chart

Other Operating Expenses

Total Operating Expenses

Cost Of Revenue

Pasithea Therapeutics income statement Correlations

Pasithea Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Pasithea Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Income Tax Expense	+ 1.0	Depreciation And Amortization
Selling And Marketing Expenses	+ 1.0	Depreciation And Amortization
Ebitda	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income
Net Income	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Ebitda

Net Income	- 1.0	Total Other Income Expense Net
Total Other Income Expense Net	- 1.0	Income Before Tax
Net Income	- 1.0	Total Operating Expenses
Income Before Tax	- 1.0	Total Operating Expenses
Total Other Income Expense Net	- 1.0	Ebitda
Total Operating Expenses	- 1.0	Ebitda